HCA DCF Analysis: Intrinsic Value $740 vs Price $435

gurufocus.com · 2026-10-06

On October 06, 2026, we conducted a DCF analysis for HCA Healthcare Inc (HCA), a company currently priced at $434.92. Despite a year-to-date decline of 6.3%, th

TickrTrends take: HCA's discounted cash flow analysis suggests the stock may be trading below its calculated intrinsic value, which could interest investors focused on valuation metrics. However, TickrTrends currently rates the stock as fairly valued, indicating that market consensus may not fully align with the DCF model's assessment. Investors watching this healthcare company should monitor whether the gap between the DCF-derived intrinsic value and the current market price narrows over time, as this divergence could signal either undervaluation or model assumptions that require reassessment.

Read the full story at gurufocus.com →